Jonathan Barratt, PhD, FRCP
Professor of Renal Medicine
University of Leicester
Leicester, United Kingdom
Consulting and Speaker Fees for Alexion, Biogen, Calliditas, Dimerix, Novartis, Otsuka, Roche, Takeda, Travere Therapeutics, Vera Therapeutics, Vertex
Grant Support for Argenx, Calliditas, Novartis, Travere Therapeutics, Otsuka
Dana V. Rizk, MD
Professor of Medicine Department of Medicine
Associate Dean for Clinical Trials Research
Heersink School of Medicine
Director of Clinical Trials in the
Division of Nephrology
University of Alabama at Birmingham
Birmingham, Alabama, USA
Consulting for Novartis (Chinook) Pharmaceuticals, George Clinical, Otsuka Pharmaceuticals (Visterra), Calliditas Therapeutics (Pharmalink), LaRoche, Vera Therapeutics, BioCryst, Chugai, Biogen (HiBio), Timberlyne Therapeutics.
Ad board honoraria for Calliditas Therapeutics (Pharmalink), Novartis (Chinook) Pharmaceuticals, Otsuka Pharmaceuticals, Vera Therapeutics, BioCryst, Argenx, Alpine Immune Science, GSK
Co-founder of Reliant Glycosciences LLC
